Global Myelodysplastic Syndrome Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • ID:PD038626
  • June 2019
  • GIR (Global Info Research)
                          

The Global Myelodysplastic Syndrome Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.

Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature and therefore do not become healthy blood cells.[2] Early on there are typically no symptoms.Later symptoms may include feeling tired, shortness of breath, easy bleeding, or frequent infections.[2] Some types may develop into acute myeloid leukemia.

Scope of the Report:
The presence of diagnostic tools is the key driver for the growth of this market. Diagnosis techniques like blood count, peripheral blood smear test, microscopic exams, cytochemistry, flow cytometry and immunotherapy, cytogenetics, FISH, and PCR help in the detection of MDS.

Consequently, these diagnostic tools are expected to have a positive impact on the usage of drugs for people suffering from MDS. 

The worldwide market for Myelodysplastic Syndrome is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019.

This report focuses on the Myelodysplastic Syndrome in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

  •     Celgene
  •     Novartis
  •     Otsuka
  •     Actinium Pharmaceuticals
  •     Acceleron Pharma
  •     Bellicum Pharmaceuticals
  •     Cornerstone Pharmaceuticals
  •     CTI BioPharma
  •     Onconova Therapeutics
  •     Strategia Therapeutics
  •     KaloBios Pharmaceuticals
  •     Kiadis Pharma
  •     Mirati Therapeutics
  •     Astex
  •     Celator Pharmaceuticals
  •     Eli-lilly
  •     Sunesis Pharmaceuticals
  •     Targazyme
  •     Gamida Cell
  •     GlaxoSmithKline
  •     Sumitomo Dainippon Pharma
  •     TetraLogic Pharmaceuticals

Market Segment by Regions, regional analysis covers
  •     North America (United States, Canada and Mexico)
  •     Europe (Germany, France, UK, Russia and Italy)
  •     Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  •     South America (Brazil, Argentina, Colombia etc.)
  •     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
  •     Alkylating Agents
  •     Cytotoxic Antibiotics
  •     Topoisomerase Inhibitors
  •     Others

Market Segment by Applications, can be divided into
  •     Hospital
  •     Clinic

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Myelodysplastic Syndrome product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Myelodysplastic Syndrome, with price, sales, revenue and global market share of Myelodysplastic Syndrome in 2017 and 2018.
Chapter 3, the Myelodysplastic Syndrome competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Myelodysplastic Syndrome breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Myelodysplastic Syndrome market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Myelodysplastic Syndrome sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Myelodysplastic Syndrome Introduction
    1.2 Market Analysis by Type
        1.2.1 Alkylating Agents
        1.2.2 Cytotoxic Antibiotics
        1.2.3 Topoisomerase Inhibitors
        1.2.4 Others
    1.3 Market Analysis by Applications
        1.3.1 Hospital
        1.3.2 Clinic
    1.4 Market Analysis by Regions
        1.4.1 North America (United States, Canada and Mexico)
            1.4.1.1 United States Market States and Outlook (2014-2024)
            1.4.1.2 Canada Market States and Outlook (2014-2024)
            1.4.1.3 Mexico Market States and Outlook (2014-2024)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2014-2024)
            1.4.2.2 France Market States and Outlook (2014-2024)
            1.4.2.3 UK Market States and Outlook (2014-2024)
            1.4.2.4 Russia Market States and Outlook (2014-2024)
            1.4.2.5 Italy Market States and Outlook (2014-2024)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2014-2024)
            1.4.3.2 Japan Market States and Outlook (2014-2024)
            1.4.3.3 Korea Market States and Outlook (2014-2024)
            1.4.3.4 India Market States and Outlook (2014-2024)
            1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2014-2024)
            1.4.4.2 Egypt Market States and Outlook (2014-2024)
            1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
            1.4.4.4 South Africa Market States and Outlook (2014-2024)
            1.4.4.5 Turkey Market States and Outlook (2014-2024)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Celgene
        2.1.1 Business Overview
        2.1.2 Myelodysplastic Syndrome Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 Celgene Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.2 Novartis
        2.2.1 Business Overview
        2.2.2 Myelodysplastic Syndrome Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Novartis Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.3 Otsuka
        2.3.1 Business Overview
        2.3.2 Myelodysplastic Syndrome Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 Otsuka Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.4 Actinium Pharmaceuticals
        2.4.1 Business Overview
        2.4.2 Myelodysplastic Syndrome Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Actinium Pharmaceuticals Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.5 Acceleron Pharma
        2.5.1 Business Overview
        2.5.2 Myelodysplastic Syndrome Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 Acceleron Pharma Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.6 Bellicum Pharmaceuticals
        2.6.1 Business Overview
        2.6.2 Myelodysplastic Syndrome Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Bellicum Pharmaceuticals Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.7 Cornerstone Pharmaceuticals
        2.7.1 Business Overview
        2.7.2 Myelodysplastic Syndrome Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Cornerstone Pharmaceuticals Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.8 CTI BioPharma
        2.8.1 Business Overview
        2.8.2 Myelodysplastic Syndrome Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 CTI BioPharma Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.9 Onconova Therapeutics
        2.9.1 Business Overview
        2.9.2 Myelodysplastic Syndrome Type and Applications
            2.9.2.1 Product A
            2.9.2.2 Product B
        2.9.3 Onconova Therapeutics Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.10 Strategia Therapeutics
        2.10.1 Business Overview
        2.10.2 Myelodysplastic Syndrome Type and Applications
            2.10.2.1 Product A
            2.10.2.2 Product B
        2.10.3 Strategia Therapeutics Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.11 KaloBios Pharmaceuticals
        2.11.1 Business Overview
        2.11.2 Myelodysplastic Syndrome Type and Applications
            2.11.2.1 Product A
            2.11.2.2 Product B
        2.11.3 KaloBios Pharmaceuticals Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.12 Kiadis Pharma
        2.12.1 Business Overview
        2.12.2 Myelodysplastic Syndrome Type and Applications
            2.12.2.1 Product A
            2.12.2.2 Product B
        2.12.3 Kiadis Pharma Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.13 Mirati Therapeutics
        2.13.1 Business Overview
        2.13.2 Myelodysplastic Syndrome Type and Applications
            2.13.2.1 Product A
            2.13.2.2 Product B
        2.13.3 Mirati Therapeutics Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.14 Astex
        2.14.1 Business Overview
        2.14.2 Myelodysplastic Syndrome Type and Applications
            2.14.2.1 Product A
            2.14.2.2 Product B
        2.14.3 Astex Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.15 Celator Pharmaceuticals
        2.15.1 Business Overview
        2.15.2 Myelodysplastic Syndrome Type and Applications
            2.15.2.1 Product A
            2.15.2.2 Product B
        2.15.3 Celator Pharmaceuticals Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.16 Eli-lilly
        2.16.1 Business Overview
        2.16.2 Myelodysplastic Syndrome Type and Applications
            2.16.2.1 Product A
            2.16.2.2 Product B
        2.16.3 Eli-lilly Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.17 Sunesis Pharmaceuticals
        2.17.1 Business Overview
        2.17.2 Myelodysplastic Syndrome Type and Applications
            2.17.2.1 Product A
            2.17.2.2 Product B
        2.17.3 Sunesis Pharmaceuticals Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.18 Targazyme
        2.18.1 Business Overview
        2.18.2 Myelodysplastic Syndrome Type and Applications
            2.18.2.1 Product A
            2.18.2.2 Product B
        2.18.3 Targazyme Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.19 Gamida Cell
        2.19.1 Business Overview
        2.19.2 Myelodysplastic Syndrome Type and Applications
            2.19.2.1 Product A
            2.19.2.2 Product B
        2.19.3 Gamida Cell Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.20 GlaxoSmithKline
        2.20.1 Business Overview
        2.20.2 Myelodysplastic Syndrome Type and Applications
            2.20.2.1 Product A
            2.20.2.2 Product B
        2.20.3 GlaxoSmithKline Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.21 Sumitomo Dainippon Pharma
        2.21.1 Business Overview
        2.2.2 Myelodysplastic Syndrome Type and Applications
            2.21.2.1 Product A
            2.21.2.2 Product B
        2.21.3 Sumitomo Dainippon Pharma Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.22 TetraLogic Pharmaceuticals
        2.22.1 Business Overview
        2.22.2 Myelodysplastic Syndrome Type and Applications
            2.22.2.1 Product A
            2.22.2.2 Product B
        2.22.3 TetraLogic Pharmaceuticals Myelodysplastic Syndrome Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Myelodysplastic Syndrome Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
    3.1 Global Myelodysplastic Syndrome Sales and Market Share by Manufacturer (2017-2018)
    3.2 Global Myelodysplastic Syndrome Revenue and Market Share by Manufacturer (2017-2018)
    3.3 Market Concentration Rate
        3.3.1 Top 3 Myelodysplastic Syndrome Manufacturer Market Share in 2018
        3.3.2 Top 6 Myelodysplastic Syndrome Manufacturer Market Share in 2018
    3.4 Market Competition Trend
4 Global Myelodysplastic Syndrome Market Analysis by Regions
    4.1 Global Myelodysplastic Syndrome Sales, Revenue and Market Share by Regions
        4.1.1 Global Myelodysplastic Syndrome Sales and Market Share by Regions (2014-2019)
        4.1.2 Global Myelodysplastic Syndrome Revenue and Market Share by Regions (2014-2019)
    4.2 North America Myelodysplastic Syndrome  Sales and Growth Rate (2014-2019)
    4.3 Europe Myelodysplastic Syndrome  Sales and Growth Rate (2014-2019)
    4.4 Asia-Pacific Myelodysplastic Syndrome  Sales and Growth Rate (2014-2019)
    4.5 South America Myelodysplastic Syndrome  Sales and Growth Rate (2014-2019)
    4.6 Middle East and Africa Myelodysplastic Syndrome  Sales and Growth Rate (2014-2019)
5 North America Myelodysplastic Syndrome by Country
    5.1 North America Myelodysplastic Syndrome Sales, Revenue and Market Share by Country
        5.1.1 North America Myelodysplastic Syndrome Sales and Market Share by Country (2014-2019)
        5.1.2 North America Myelodysplastic Syndrome Revenue and Market Share by Country (2014-2019)
    5.2 United States Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    5.3 Canada Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    5.4 Mexico Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
6 Europe Myelodysplastic Syndrome by Country
    6.1 Europe Myelodysplastic Syndrome Sales, Revenue and Market Share by Country
        6.1.1 Europe Myelodysplastic Syndrome Sales and Market Share by Country (2014-2019)
        6.1.2 Europe Myelodysplastic Syndrome Revenue and Market Share by Country (2014-2019)
    6.2 Germany Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    6.3 UK Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    6.4 France Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    6.5 Russia Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    6.6 Italy Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
7 Asia-Pacific Myelodysplastic Syndrome by Country
    7.1 Asia-Pacific Myelodysplastic Syndrome Sales, Revenue and Market Share by Country
        7.1.1 Asia-Pacific Myelodysplastic Syndrome Sales and Market Share by Country (2014-2019)
        7.1.2 Asia-Pacific Myelodysplastic Syndrome Revenue and Market Share by Country (2014-2019)
    7.2 China Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    7.3 Japan Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    7.4 Korea Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    7.5 India Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    7.6 Southeast Asia Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
8 South America Myelodysplastic Syndrome by Country
    8.1 South America Myelodysplastic Syndrome Sales, Revenue and Market Share by Country
        8.1.1 South America Myelodysplastic Syndrome Sales and Market Share by Country (2014-2019)
        8.1.2 South America Myelodysplastic Syndrome Revenue and Market Share by Country (2014-2019)
    8.2 Brazil Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    8.3 Argentina Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    8.4 Colombia Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
9 Middle East and Africa Myelodysplastic Syndrome by Countries
    9.1 Middle East and Africa Myelodysplastic Syndrome Sales, Revenue and Market Share by Country
        9.1.1 Middle East and Africa Myelodysplastic Syndrome Sales and Market Share by Country (2014-2019)
        9.1.2 Middle East and Africa Myelodysplastic Syndrome Revenue and Market Share by Country (2014-2019)
    9.2 Saudi Arabia Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    9.3 Turkey Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    9.4 Egypt Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    9.5 Nigeria Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
    9.6 South Africa Myelodysplastic Syndrome Sales and Growth Rate (2014-2019)
10 Global Myelodysplastic Syndrome Market Segment by Type
    10.1 Global Myelodysplastic Syndrome Sales, Revenue and Market Share by Type (2014-2019)
        10.1.1 Global Myelodysplastic Syndrome Sales and Market Share by Type (2014-2019)
        10.1.2 Global Myelodysplastic Syndrome Revenue and Market Share by Type (2014-2019)
    10.2 Alkylating Agents Sales Growth and Price
        10.2.1 Global Alkylating Agents Sales Growth (2014-2019)
        10.2.2 Global Alkylating Agents Price (2014-2019)
    10.3 Cytotoxic Antibiotics Sales Growth and Price
        10.3.1 Global Cytotoxic Antibiotics Sales Growth (2014-2019)
        10.3.2 Global Cytotoxic Antibiotics Price (2014-2019)
    10.4 Topoisomerase Inhibitors Sales Growth and Price
        10.4.1 Global Topoisomerase Inhibitors Sales Growth (2014-2019)
        10.4.2 Global Topoisomerase Inhibitors Price (2014-2019)
    10.5 Others Sales Growth and Price
        10.5.1 Global Others Sales Growth (2014-2019)
        10.5.2 Global Others Price (2014-2019)
11 Global Myelodysplastic Syndrome Market Segment by Application
    11.1 Global Myelodysplastic Syndrome Sales Market Share by Application (2014-2019)
    11.2 Hospital Sales Growth (2014-2019)
    11.3 Clinic Sales Growth (2014-2019)
12 Myelodysplastic Syndrome Market Forecast (2019-2024)
    12.1 Global Myelodysplastic Syndrome Sales, Revenue and Growth Rate (2019-2024)
    12.2 Myelodysplastic Syndrome Market Forecast by Regions (2019-2024)
        12.2.1 North America Myelodysplastic Syndrome Market Forecast (2019-2024)
        12.2.2 Europe Myelodysplastic Syndrome Market Forecast (2019-2024)
        12.2.3 Asia-Pacific Myelodysplastic Syndrome Market Forecast (2019-2024)
        12.2.4 South America Myelodysplastic Syndrome Market Forecast (2019-2024)
        12.2.5 Middle East and Africa Myelodysplastic Syndrome Market Forecast (2019-2024)
    12.3 Myelodysplastic Syndrome Market Forecast by Type (2019-2024)
        12.3.1 Global Myelodysplastic Syndrome Sales Forecast by Type (2019-2024)
        12.3.2 Global Myelodysplastic Syndrome Market Share Forecast by Type (2019-2024)
    12.4 Myelodysplastic Syndrome Market Forecast by Application (2019-2024)
        12.4.1 Global Myelodysplastic Syndrome Sales Forecast by Application (2019-2024)
        12.4.2 Global Myelodysplastic Syndrome Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source

Related Reports
Global Population Health Management Market Research Report 2017

The Global Population Health Management Market Research Report provides a detailed market overview along with the analysis of industry’s gross  read more..


Global Water Distiller Industry 2016 Market Research Report

The Global Water Distiller Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Water Distiller  read more..


EMEA (Europe, Middle East and Africa) Hepatitis A Vaccine Market Report 2017

The EMEA (Europe, Middle East and Africa) Hepatitis A Vaccine Market Research Report provides a detailed market overview along with the analysis of  read more..


Global Health Insurance Market Report 2019-2025

The Health Insurance market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This report also  read more..


Global Boat First Aid Kits Industry 2016 Market Research Report

The Global Boat First Aid Kits Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Boat First Aid Kits  read more..


Global Facial Aesthetics Market Report 2018-2025

The Global Facial Aesthetics Market report is a recent research added by DecisionDatabases.com, offers critical insight into the market dynamic. This  read more..


Global Spinal Fixation Systems Market Research Report 2017

The Global Spinal Fixation Systems Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin,  read more..


Global Vascular Graft Market Research Report 2017

The Global Vascular Graft Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


Global Blood Products Market Report 2018-2025

The Global Blood Products Market report is a recent research added by DecisionDatabases.com, offers critical insight into the market dynamic. This report  read more..


Global Nateglinide Market Research Report 2021

The Global Nateglinide Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..